Lumexa Imaging (NASDAQ:LMRI) Shares Up 11.9% After Analyst Upgrade

Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) shares traded up 11.9% on Tuesday after Raymond James Financial upgraded the stock from an outperform rating to a strong-buy rating. Raymond James Financial now has a $23.00 price target on the stock. Lumexa Imaging traded as high as $12.98 and last traded at $12.93. 133,065 shares traded hands during mid-day trading, a decline of 79% from the average session volume of 629,993 shares. The stock had previously closed at $11.55.

Hedge Funds Weigh In On Lumexa Imaging

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Assetmark Inc. bought a new stake in Lumexa Imaging in the 4th quarter worth about $36,000. Geode Capital Management LLC purchased a new stake in Lumexa Imaging during the 4th quarter valued at $1,548,000. Finally, Seven Grand Managers LLC bought a new position in shares of Lumexa Imaging during the 4th quarter valued at $11,942,000.

Lumexa Imaging Trading Up 11.9%

Lumexa Imaging Company Profile

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).